Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.720
-0.290 (-7.23%)
At close: Jun 13, 2025, 4:00 PM
3.870
+0.150 (4.03%)
After-hours: Jun 13, 2025, 4:04 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $39.43 million as of June 13, 2025. Its market cap has increased by 70.71% in one year.
Market Cap
39.43M
Enterprise Value
39.86M
1-Year Change
70.71%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $39.43M, a decrease of -27.11%. That is a compound annual growth rate of -5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 42.50M | 174.19% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |